We found that high IL-17RA expression in patients with CRC tumors was negatively correlated with survival and positively correlated with the expression of CSC markers CD133, LGR5, and ALDH2, and CSC markers SOX2 and c-MYC. Here, IL17RA is linked to colorectal carcinoma.